Abstract:Background and aim Portal hypertension is a common complication of chronic liver diseases responsible for most liver cirrhosis consequences. In patients with portal hypertension, oesophagogastric variceal bleeding is a leading cause of death. Most research has focused on high-risk gastroesophageal varices and bleeding, with only a few studies on early varices. However, early intervention of gastroesophageal varices was found to better improve the prognosis and reduce mortality, but there is still no relevant research. Ultrasonic endoscopy is a combination of endoscopy and ultrasonic imaging. It can gastroscopically detect varices around the oesophagus and stomach and detect oesophageal collateral veins and perforating veins earlier, which is helpful for the early diagnosis of varices. Therefore, this study aimed to explore the correlation between serum fibrosis markers and early gastroesophageal varices in compensated cirrhosis patients. Methods This study included 791 patients with compensated cirrhosis. The selected patients were categorized into three groups. The early gastroesophageal varices group included patients with gastroesophageal varices found by endoscopic ultrasonography but not by gastroscopy. The no gastroesophageal varices group underwent endoscopic ultrasonography and gastroscopy without varices. In addition, gastroesophageal varices can be detected with both techniques. Multiple logistic regression analysis explored the association of serum fibrosis markers with early gastroesophageal varices. Results Among the 791 compensated liver cirrhosis patients, 198 patients were without gastroesophageal varices, 279 patients had early gastroesophageal varices, 314 patients had gastroesophageal varices, and both techniques could detect varices. There was a positive correlation between serum fibrosis markers and early gastroesophageal varices. In univariate logistic regression analysis, the patients with early gastroesophageal varices had lower platelet counts ( P = 0.034) and higher aspartate aminotransferase ( P = 0.046), total bilirubin ( P = 0.041), hyaluronic acid ( P < 0.001), laminin ( P < 0.001), type III procollagen ( P = 0.005), type IV collagen ( P = 0.002), liver stiffness measurement ( P = 0.001), APRI ( P = 0.019) and FIB-4 ( P = 0.002). Multivariate analysis showed that laminin (OR 1.011; 95% CI 1.004-1.017, P = 0.001) was an independent risk factor for predicting early gastroesophageal varices in compensated cirrhosis patients. Conclusion Higher laminin was independently associated with early gastroesophageal varices in compensated cirrhosis patients.

Insulin Resistance is a Risk Factor for Esophageal Varices in Hepatitis C Virus Cirrhosis

Clinical analysis of insulin resistance in liver cirrhosis patients

Transient Elastography Identifies the Risk of Esophageal Varices and Bleeding in Patients With Hepatitis B Virus–Related Liver Cirrhosis

Portal Vein Thrombosis Can Aggravate Esophageal Variceal Bleeding After Endoscopic Variceal Ligation

Endoscopic ultrasonography predicts early esophageal variceal bleeding in liver cirrhosis: A case report

Evaluation of non-invasive diagnostic markers on the presence of esophageal varices in cirrhotic patients

Risk Factors for Esophageal Collateral Veins in Cirrhosis with and Without Previous Endoscopic Esophageal Variceal Therapy

Non-invasive Model for Predicting Esophageal Varices Based on Liver and Spleen Volume

Risk Factors Associated with Failure of Endoscopic Combined Treatment to Prevent Varices Rebleeding in Patients with Liver Cirrhosis

Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two-center retrospective study

The Combination of Shear Wave Elastography and Platelet Counts Can Effectively Predict High-Risk Varices in Patients with Hepatitis B-Related Cirrhosis

Platelet Count/Spleen Diameter Ratio for Prediction of Esophageal Varices in Patients with HBV-related Cirrhosis: A Clinical Study

Esophageal varices bleeding with liver cirrhosis studied with Doppler ultrasonography

The ratio of platelet count/spleen diameter and albumin as non-invasive parameters to predict the presence of esophageal varices in patients with liver cirrhosis

Evaluation of non-invasive marker of esophageal varices in cirrhosis of liver

Clinical characteristics and predictors of esophagogastric variceal bleeding among patients with HCV-induced liver cirrhosis: An observational comparative study

Insulin Resistance is Associated with Hepatocellular Carcinoma in Chronic Hepatitis C Infection

Non-Invasive Prediction Models for Esophageal Varices and Red Signs in Patients With Hepatitis B Virus-Related Liver Cirrhosis

Correlation Between Serum Liver Fibrosis Markers and Early Gastroesophageal Varices among Patients with Compensated Liver Cirrhosis: a Cross-Sectional Analysis.

[Value of Endoscopic Ultrasound in Early Diagnosis of Gastroesophageal Varices in Patients with Liver Cirrhosis].

Cystatin C/albumin ratio for early diagnosis of esophageal varices in liver cirrhosis